Gianluigi Savarese is an expert in Cardiology at Karolinska Institute (Sweden). As of October 2026, ScienceLeadR ranks Gianluigi Savarese in the top 1% of experts worldwide for Heart Failure. Gianluigi Savarese has authored 564 publications, the most recent in 2026, and is an investigator in 7 clinical trials, 2 of them ongoing. SLR score: 2,441 (community average: 125). How the SLR is computed.

LeadR Profile

Gianluigi Savarese Karolinska Institute Sweden
2 441 ScienceLeadR Reputation 2441
Network Map

Cardiology

Subspecialties: Public Health - Endocrinology - Pharmacy

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Short Biography

Gianluigi Savarese is an Italian/Swedish cardiologist, currently Professor of Cardiology at Karolinska Institutet (Department of Clinical Science and Education) where he is head of the Center for Heart Failure and Arrhythmia. He is also Senior Consultant for Heart Failure at the Southern Hospital, Stockholm, Sweden. Over the last few years, he has published >400 articles on top peer reviewed journals. Major focus of his research is heart failure, with a particular interest in implementing use of guidelines recommended treatments, and phenotyping heart failure for improving clinical trial design. He is heavily involved in registry studies (Swedish Heart Failure Registry, ESC registries) and clinical trials, and he is expert in big data analysis. He is Secretary of the Heart Failure Association and he has served as board member and secretary of the Working Group on Cardiovascular Pharmacotherapy of the European Society of Cardiology. Among others, he is Deputy Editor of European Journal of Heart Failure, EHJ-Open, and Associate Editor of JACC: Heart Failure.

Organizations

Career arc: 2012 - 2026

Source: PubMed

Karolinska Institute

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 564

Citations

Citations: 20 239 1st author: 95 Last author: 113 Unique author: 5


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Enhancing heart failure care through registries: lessons learned from Nordic Countries' implementation of guidelines.
PMID 41789668 — registries, heart failure, heart, heart failure, systolic, therapeutics
Eur J Heart Fail20260
A NETwork meta-analysis with COST-effectiveness evaluation of pharmacological treatments for heart failure with reduced ejection fraction: NET-COST-HFrEF.
PMID 42462167 — heart failure, heart, network meta-analysis, heart failure, systolic, therapeutics
Eur J Heart Fail20261
Beyond HFmrEF: New Classification, Unchanged Treatment Evidence.
PMID 42949675 — heart failure, heart failure, diastolic, classification, cardiology, therapeutics
J Am Coll Cardiol20260
Short-term survival of dual SGLT2i-MRA and four-class guideline-directed medical therapy in acute heart failure.
PMID 42484006 — registries, mortality, heart failure, heart, therapeutics
Eur J Heart Fail20262
Trends in mortality, heart transplantation, and left ventricular assist device use in advanced heart failure between 2003 and 2022: data from the Swedish Heart Failure Registry.
PMID 42485618 — registries, mortality, heart failure, heart, heart failure, systolic, heart transplantation, therapeutics, transplantation, prognosis
Eur J Heart Fail20261

Clinical Studies 7

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 4
Phase 2/Phase 3 1
Phase 3 1
Phase 4 1

By status:

Completed 4
Recruiting 3

By type:

Interventional 4
Observational 3

By Monocentric/Multicentric:

monocentric 2
multicentric2to4 0
multicentric5to9 1
multicentricup10 4

Main Topics

Ongoing Clinical Trials

2 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
A Study of the Efficacy and Safety of Danicamtiv in Participants with Symptomatic Genetic and Familial Dilated Cardiomyopathy
2025-522553-19-00 — exercise, cardiomyopathy, dilated, safety, cardiomyopathies
Phase 2/Phase 3Recruiting2026
Registry BAsed Optimization Of Therapy in Heart Failure
NCT07154758 — registries, heart failure, pharmaceutical preparations, heart, mass screening, ambulatory care facilities, heart failure, systolic, therapeutics, outpatients
N/ARecruiting2024

LeadR Networks

Main global connection map